The beauty industry has long harnessed biotechnology — namely taking the most powerful skincare ingredients in nature and recreating them using science to make them more potent, stable, ...

Biotechnology is no longer distant science fiction; it’s already a growing force in both national security and local economies. It affects everything from how much you pay at the pharmacy to whether ...

Get the latest federal technology news delivered to your inbox. The congressional working group on the national security ramifications of biotechnology is angling to publish and deliver new policy ...

Puma Biotechnology, Inc. (NASDAQ:PBYI) is one of the best affordable biotech stocks to invest in now. Puma Biotechnology, Inc. (NASDAQ:PBYI) reported its fiscal Q2 2025 results on August 7, with ...

We’re hoping to see more early-stage funding in 2026 to help newer companies get off the ground. The public market, especially IPOs, has been a bit slow, with only 11 companies going public in 2025, ...

BioTechAnalyzer is a research and analytics platform focused on making complex FDA-related biotechnology information clear, accessible, and actionable for investors. The platform focuses on late-stage ...

Recognition underscores ValGenesis’ pioneering leadership and continued innovation in digital validation and AI-enabled lifecycle management. ValGenesis, the market leader in enterprise validation ...

BASKING RIDGE, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the ...

Cathie Wood aims to identify innovators and invest in them early in their stories. Wood has been regularly adding to her position in this stock, and it’s one of her top holdings. This company's first ...

Nanobiotix is a small French biotechnology company. It has secured financing from Johnson & Johnson and elsewhere. It's not a no-brainer investment, but it might do well. Nanobiotix (NASDAQ: NBTX) is ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...